Frank Berlinghoff

HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US.

Oterittezrag Holding AG provides investment services. The private company is based in Zurich, Switzerland.

Sudpack Medica designs and manufactures medical plastic packaging solutions. The private company is based in Baar, Switzerland.

Hk Real Estate AG is a Swiss company that buys and sells real estate properties. The private company is based in Zug, Switzerland.

Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland.

INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018.

Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019.

Thommen Medical AG develops and manufactures dental implant systems. It offers include implants, prosthetics, digital solutions, and case planning. The company Grenchen, Switzerland.

Part of NN, Inc., Southeastern Technology, Inc. operates as a contract manufacturer of machined components, assemblies, and engineered solutions for the medical device industry. The company is based in Murfreesboro, TN. Southeastern Technology was acquired by Autocam Medical Device Holdings LLC on December 02, 2014.

Tensys Medical, Inc. develops blood pressure monitoring systems. The firm provides patient safety by designing, and manufacturing continuous, non-invasive hemodynamic monitoring systems. The company was founded in 1995 and is headquartered in San Diego, CA.

Advanced Osteotomy Tools-AOT AG develops, manufactures, and markets medical devices and tools for bone-cutting. Its device combines three-dimensional (3D) pre-operative planning and a navigation system with a miniaturized laser mounted on a robotic arm. The company was founded by Alfredo E. Bruno, Philippe Cattin, Philipp Jürgens, and Hans-Florian Zeilhofer in 2011 and is headquartered in Allschwil, Switzerland.

SE Swiss Equities AG is an investment company with a focus on the pharmaceutical industry. The private company is based in Zurich, Switzerland. Reto A. Garzetti has been the CEO of the company since 1998.

SETECH, Inc. provides consulting and engineering services. The private company is based in Madison, TN. The CEO of the company is William Shriver.

Occlutech International AB develops and supplies occluders, accessories, and special cardiac implant products. Its products include Occlutech muscular ventricular septal defect, programmable logic device, sizing balloon, Figulla Flex II, sizing Occlutech autism spectrum disorder, and PDA occluder. The company is headquartered in Helsingborg, Sweden.

HFS Helvetic Financial Services AG provides consulting services. The firm offers funds management, investment, and other financial services. The company was founded by Norbert Ketterer in 2009 and is headquartered in Wollerau, Switzerland.

Occlutech GmbH develops and markets occluders and medical implants. Its products include Occlutech’s muscular VSD which allows for the creation of products, Occlutech PLD, Occlutech stiff guide wire and Occlutech sizing ballon. The company was founded in 2003 and is headquartered in Jena, Germany.